Wall Street JournalEN
A
APS
Aptose Bio
0.26
-0.01-3.70%Opening13:17 02/05 EST
OPEN/PREV CLOSE0.270/0.270
TODAY RANGE0.260-0.275
VOL9.67K
MARKET CAP15.65M
52 WEEK RANGE0.190-2.940
AVG VOL (3M)40.64K
% TURNOVER0.02%
TURNOVER1.34K
P/E (TTM)-0.0306
% RANGE5.56%
EPS(TTM)-8.5022
P/E(FORWARD)-0.1014
P/B22.03
BVPS0.012
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP14.69M
SHARES OUTSTANDING60.18M
NEXT EARNINGS03/24-03/28
FREE FLOAT56.51M
LOT SIZE500
EX-DIV DATE06/06/2023
News
Press Releases
Financial Reports
Profile
Dow Jones·12/10/2024 12:01
Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.
Dow Jones·12/03/2024 17:31
Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.
Dow Jones·11/20/2024 18:11
Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·11/20/2024 18:11
Aptose Biosciences Price Target Cut to $2.00/Share From $7.00 by HC Wainwright & Co.
Dow Jones·11/08/2024 21:01
*Aptose Biosciences 3Q Loss/Shr 37c >APTO
Dow Jones·08/08/2024 21:12
*Aptose Biosciences Sees Funding Sufficient Through August >APTO
Dow Jones·06/18/2024 21:30
Press Release: Aptose Announces Results from Annual and Special Meeting of Shareholders
Dow Jones·06/14/2024 15:13
Aptose Biosciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Dow Jones·05/16/2024 15:57
Aptose Biosciences Price Target Cut to $6.00/Share From $15.00 by Canaccord Genuity
Dow Jones·05/16/2024 15:57
Aptose Biosciences Is Maintained at Buy by Canaccord Genuity
Dow Jones·05/14/2024 20:05
*Aptose Biosciences 1Q Loss/Shr 73c >APTO
Dow Jones·05/14/2024 20:01
Press Release: Aptose Reports Results for the -2-
Dow Jones·04/03/2024 16:09
Aptose Biosciences Is Maintained at Overweight by Piper Sandler
Dow Jones·04/03/2024 16:09
Aptose Biosciences Price Target Maintained With a $5.00/Share by Piper Sandler
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others